
    
      After completing the study inclusion criteria, the individual will be invited to participate
      and will receive the consent form for signature.

      The patient will be submitted to the following evaluations: quality of life questionnaire for
      cystic fibrosis, spirometry, Shwachman-Kulczycki score, modified dyspnea questionnaire
      (Modified Medical Research Council), maximum repetition test, six minute walk test and blood
      sample for the determination of inflammatory markers. These evaluations should be performed
      within the first 48 hours of hospitalization, and will be repeated on the last day of
      hospitalization.

      In the period up to 48 hours after hospital admission, patients will be randomized to either
      the intervention group or the control group.
    
  